PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
06-Sep-2022 Companion Diagnostics Market Worth US$16,056 million by 2031: Visiongain Reports Ltd Visiongain Reports Limited
06-Sep-2022 Immutep announces investigator-initiated Phase II trial evaluating LAG-3 candidate eftilagimod alpha (efti) in soft tissue sarcoma Immutep
06-Sep-2022 Enterome to present updates on EO2401, its first-in-class OncoMimics™ therapeutic cancer vaccine targeting solid tumors, at ESMO Congress 2022 Enterome
06-Sep-2022 Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs Avance Clinical
06-Sep-2022 Late-breaking Dupixent® (dupilumab) data at ERS 2022 show consistent efficacy and safety profile for up to two years in children aged 6 to 11 years with moderate-to-severe asthma Sanofi
05-Sep-2022 Novotech at ESMO Congress 2022 - New Data Shows 100% Oncology Trials Growth in APAC Novotech Health Holdings Pte Ltd
03-Sep-2022 APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report Novotech Health Holdings Pte Ltd
01-Sep-2022 Clinical trials legal service provider cements expansion plans with first US office CTA Focus
01-Sep-2022 JAMA Neurology Publishes Positive Pivotal Clinical Trial with Vamorolone in Duchenne Muscular Dystrophy Santhera Pharmaceuticals
01-Sep-2022 EpiEndo Commences LPS Challenge Trial for Lead Candidate EP395 EpiEndo Pharmaceuticals
31-Aug-2022 RECORDATI RARE DISEASES ANNOUNCE PUBLICATION OF LONG-TERM OUTCOMES FROM THE EXTENSION TO THE PHASE III LINC 3 STUDY OF ISTURISA® (OSILODROSTAT) IN PATIENTS WITH CUSHING’S DISEASE IN THE EUROPEAN JOURNAL OF ENDOCRINOLOGY Recordati Rare Diseases
30-Aug-2022 Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio AcuraBio / Ampersand Capital Partners
30-Aug-2022 Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future CluePoints
30-Aug-2022 Kinarus Therapeutics initiates KIN001 Phase II KINFAST clinical trial in COVID-19 outpatients Kinarus Therapeutics
29-Aug-2022 Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022 Avance Clinical
26-Aug-2022 Pharma Contract Sales market set to grow at a CAGR of 5.8% by 2031: Visiongain Reports Ltd Visiongain Reports Limited
26-Aug-2022 Black participants represented only 3% of cancer clinical trial participants between 2013 and 2022, finds GlobalData GlobalData
26-Aug-2022 Jazz Pharmaceuticals Announces Initiation of Phase 3 Trial Evaluating Epidiolex®/Epidyolex® (cannabidiol) for Patients with Epilepsy with Myoclonic-Atonic Seizures Jazz Pharmaceuticals
25-Aug-2022 Developments in Gene Therapy for Ocular Diseases SAE Media Group
23-Aug-2022 HUTCHMED Highlights Fruquintinib MRCT FRESCO-2 Data to be Presented at the Upcoming ESMO Congress 2022 HUTCHMED